Last updated on January 2020

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)


Brief description of study

The study to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant to first-line (1L) chemotherapy.

Clinical Study Identifier: NCT03833661

Find a site near you

Start Over

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Asan Medical Center (7978)

Seoul, Korea, Republic of
  Connect »

Mayo Clinic Arizona

Scottsdale, AZ United States
  Connect »

Mayo Clinic - Rochester

Rochester, MN United States
  Connect »

Institut Gustave Roussy

Villejuif cedex, France
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »